Skip to content

Shenzhen Dapeng proactive health cohort study

Shenzhen Dapeng proactive health cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086369
Enrollment
Unknown
Registered
2024-06-29
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pan-vascular diseases

Interventions

With new panvascular disease including MACE or MALE events (composite endpoint of cardiovascular death, myocardial infarction, ischemic stroke, acute limb ischemia, and amputation for vascular reasons

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Subjects voluntarily enrolled in the study and signed an informed consent form 2: Age 18-80 years old 3: Resident population of Dapeng New District, Shenzhen, and those with good compliance

Exclusion criteria

Exclusion criteria: 1: Those with incomplete information 2: Patients with a clear diagnosis of coronary heart disease, acute myocardial infarction, or stroke 3: Those with physical and mental disabilities who could not cooperate with the study

Design outcomes

Primary

MeasureTime frame
With new panvascular disease including MACE or MALE events (composite endpoint of cardiovascular death, myocardial infarction, ischemic stroke, acute limb ischemia, and amputation for vascular reasons);

Secondary

MeasureTime frame
All-cause mortality;Transient ischemic attack, TIA;Chronic coronary diseases;

Countries

China

Contacts

Public ContactLijie Ren

Shenzhen second people ' s hospital

renlijie72@126.com+86 136 3160 5966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026